Research groups

We work with infection epidemiology - to track infection and understand how bacteria and viruses are spread.

Amyloid Fibrils and Cytotoxic Oligomers.

Type VI secretion system of Francisella tularensis –  elucidation of its structure and assembly control.

The Överby lab is focusing on different aspects of tick-borne encephalitis virus.

text is coming soon

The research focuses on the cardiovascular complications following HFRS and the underlying mechanisms thereof.

Our group studies infectious diseases and climate change in the north.

We study disease mechanisms in two severe viral infections, hantavirus hemorrhagic fever and COVID-19, to understand disease mechanisms and be able...

Our group is interested in the basic processes of infections with pathogenic fungi.

The group's research is about the herpes virus and its role in the development of Alzheimer's disease.

Virus entry into cells: host protein networks guiding virus infection and how we can block them.

Our research is about host immunological and metabolomic responses to acute infections and vaccination.

Role of B-cells and antibodies in Type 1 diabetes.

We develop bioinformatic approaches to monitor and combat the spread of bacterial pathogens.

Pregnancy and cancer share common aims – to escape attack by the immune system.

We study viruses that are transmitted from animals or mosquitoes. Also, we develop antiviral drugs.

Our group studies colorektal cancer and biomarkers for prognosis.

Our group studies virus-membrane interactions.

We characterize how human B cells in circulation and tissues are affected by underlying disease.

Micael Widerström's research group works with infection epidemiology and infection ecology.

We study the mechanisms by which the immune system is regulated and the effects of such mechanisms on disease.

We are doing research about the molecules and mechanisms that viruses need to bind to and enter our cells.

Our research focuses on the virus-mosquito and mosquito-host interactions.

We do research on epigenetics and telomere biology in hematological malignancies.

Our research group studies novel oncolytic adenovirus 11p vectors in the treatment of human solid tumors.

We research about novel antibacterial strategies for treatment of Chlamydia.